Health Canada — Medical Devices · Canada · 2020-06-19 · Type II
As described by Health Canada — Medical Devices: VITROS 3600 Immunodiagnostic System-Instrument, 5600 Integrated System-Instrument & XT 7600 Integrated System (2020-05-26)
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Current functionality automatically updates these values for plasma when serum is updated. Both serum and plasma user modifications in the options & configuration - review/edit calibrations - review assay data screen should then be marked with M1 to ensure the modifications are retained when retain configuration is used during add load. Internal testing identified a software anomaly which occurs if the qualitative result text and/or qualitative range settings are modified by the operator for serum, the corresponding values are updated for plasma, however the M1 code is not assigned to plasma. Therefore, after loading an add and selecting retain configuration, the modified qualitative result text and qualitative ranges are retained for serum, but the plasma qualitative result text and qualitative ranges incorrectly revert to the default values validated by ortho and recommended in the vitros immunodiagnostic products instructions for use (IFU). No other parameters are affected by this issue.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.